New research from the University of East Anglia (UK) reveals the hidden struggles experienced by the brothers and sisters of people with Prader-Willi syndrome. Prader-Willi syndrome is a rare genetic ...

New research from the University of East Anglia (UK) reveals the hidden struggles experienced by the brothers and sisters of people with Prader–Willi syndrome. Prader–Willi syndrome is a rare genetic ...

Credit: Solano Therapeutics. Vykat XR contains an extended-release formulation of diazoxide choline, the crystalline salt of diazoxide. Vykat XR is expected to be available in April 2025. The Food and ...

The FDA approved extended-release diazoxide choline (Vykat XR) to treat the intense persistent sensation of hunger in patients 4 years of age and older with Prader-Willi syndrome, maker Soleno ...

Please provide your email address to receive an email when new articles are posted on . Discontinuing diazoxide choline extended release was tied to increased hyperphagia behaviors at 16 weeks in ...

POMONA ‒ When you fill up through October at the Mt. Ivy Country Corner's Shell gas pumps, a slice of the profits will go to helping kids like 3-year-old Catalina Valenti, who lives with Prader-Willi ...

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, making it the first treatment available for patients who experience ...

Man with Prader-Willi Syndrome died of multi-organ failure from a complication of undiagnosed diabetes, triggered by ...

The exterior of the Food And Drug Administration headquarters is seen on July 20, 2020, in White Oak, Maryland. This story was originally published on BioPharma Dive. To receive daily news and ...

REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced ...